Breaking News Instant updates and real-time market news.

FPRX

Five Prime

$11.00

-0.25 (-2.22%)

16:07
11/14/18
11/14
16:07
11/14/18
16:07

Five Prime initiates dosing in phase 1 clinical trial of FPT155

Five Prime Therapeutics announced it initiated patient dosing in a Phase 1 clinical trial of FPT155, a first-in-class CD80 fusion protein. The trial was initiated in Australia. The Phase 1a/1b open-label, multicenter, dose escalation, dose exploration and dose expansion study will evaluate the safety and tolerability of FPT155 in patients with advanced solid tumors. The Phase 1a dose escalation portion of the trial will characterize the safety and pharmacokinetic / pharmacodynamic profile of FPT155 and will identify a recommended dose for the Phase 1b portion of the trial. During the dose escalation, Five Prime will also open an exploratory cohort to investigate FPT155 monotherapy in select tumor types with high unmet need. The Phase 1b portion of the trial is intended to further characterize the safety, PK/PD profile, and preliminary efficacy of FPT155.

  • 27

    Nov

FPRX Five Prime
$11.00

-0.25 (-2.22%)

09/13/18
LEER
09/13/18
INITIATION
Target $24
LEER
Outperform
Five Prime resumed with an Outperform at Leerink
Leerink analyst Jonathan Chang resumed coverage of Five Prime with an Outperforn rating and $24 price target. While investors are cautious on cabiralizumab following updates at the Society for Immunotherapy of Cancer 2017 with limited visibility into future clinical updates and next development steps, MEDACorp KOLs he has spoken to remain positive on the approach. Additionally, Chang sees multiple sources of upside from his current valuation including opportunities for cabiralizumab beyond pancreatic cancer as well as Five Prime's advancing early stage pipeline including FPA150, FPT155, and BMS-986258.
08/09/18
WELS
08/09/18
NO CHANGE
Target $35
WELS
Outperform
Five Prime price target lowered to $35 from $58 at Wells Fargo
Wells Fargo analyst Jim Birchenough lowered his price target for Five Prime to $35 from $58 following review of Q2 operating results and on disappointing update on Cabira in PVNS. The analyst reiterates an Outperform rating on the shares.
06/28/18
RAJA
06/28/18
INITIATION
RAJA
Market Perform
Five Prime initiated with a Market Perform at Raymond James
06/15/18
JPMS
06/15/18
INITIATION
Target $19
JPMS
Neutral
Five Prime initiated with a Neutral at JPMorgan
JPMorgan analyst Eric Joseph started Five Prime Therapeutics with a Neutral rating and $19 price target. The analyst has some caution into the pancreatic data and expects shares to be range-bound in the near-term.

TODAY'S FREE FLY STORIES

07:53
08/22/19
08/22
07:53
08/22/19
07:53
Conference/Events
Citigroup to hold a forum »

Citi-REITAS-SGX C-Suite…

JEC

Jacobs Engineering

$86.06

2.45 (2.93%)

07:51
08/22/19
08/22
07:51
08/22/19
07:51
Hot Stocks
Jacobs Engineering appointed as smart meter specialist in Singapore »

Jacobs has been appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSGN

MSG Networks

$14.78

-2.07 (-12.28%)

07:51
08/22/19
08/22
07:51
08/22/19
07:51
Recommendations
MSG Networks analyst commentary  »

MSG Networks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$71.77

0.44 (0.62%)

07:50
08/22/19
08/22
07:50
08/22/19
07:50
Upgrade
Cerner rating change  »

Cerner upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

ADMA

ADMA Biologics

$4.05

-0.01 (-0.25%)

07:50
08/22/19
08/22
07:50
08/22/19
07:50
Hot Stocks
ADMA Biologics announces commercial relaunch of BIVIGAM »

ADMA Biologics announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

FLWS

1-800-Flowers.com

$19.36

0.74 (3.97%)

07:48
08/22/19
08/22
07:48
08/22/19
07:48
Earnings
1-800-Flowers.com sees FY20 EPS up 8%-10% »

Sees FY20 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

FLWS

1-800-Flowers.com

$19.36

0.74 (3.97%)

07:48
08/22/19
08/22
07:48
08/22/19
07:48
Earnings
1-800-Flowers.com reports Q4 adj. EPS (12c), consensus (14c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

SQM

SQM

$25.40

-0.86 (-3.27%)

07:45
08/22/19
08/22
07:45
08/22/19
07:45
Downgrade
SQM rating change  »

SQM downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

SEDG

SolarEdge

$87.87

3.16 (3.73%)

07:44
08/22/19
08/22
07:44
08/22/19
07:44
Downgrade
SolarEdge rating change  »

SolarEdge downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$84.51

2.27 (2.76%)

07:43
08/22/19
08/22
07:43
08/22/19
07:43
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:42
08/22/19
08/22
07:42
08/22/19
07:42
Hot Stocks
Dick's Sporting reports Q2 eCommerce sales up 21% »

eCommerce penetration for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

FLR

Fluor

$17.35

0.3 (1.76%)

07:41
08/22/19
08/22
07:41
08/22/19
07:41
Upgrade
Fluor rating change  »

Fluor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:40
08/22/19
08/22
07:40
08/22/19
07:40
Hot Stocks
Dick's Sporting up 10% after Q2 results beat estimates, FY19 profit view raised »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

PDD

Pinduoduo

$30.14

4.165 (16.04%)

07:39
08/22/19
08/22
07:39
08/22/19
07:39
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:38
08/22/19
08/22
07:38
08/22/19
07:38
Earnings
Dick's Sporting says FY19 EPS guidance includes expected tariff impacts »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

TGT

Target

$103.11

17.54 (20.50%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Recommendations
Target analyst commentary  »

Target valuation remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Hot Stocks
Dick's Sporting CEO says 'we are very pleased with our second quarter results' »

"We are very pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HMSY

HMS Holdings

$38.69

-0.19 (-0.49%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Downgrade
HMS Holdings rating change  »

HMS Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:35
08/22/19
08/22
07:35
08/22/19
07:35
Hot Stocks
Dick's Sporting sees FY19 CapEx approximately $230M on gross basis »

In 2019, the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

CLSD

Clearside Biomedical

$1.27

0.09 (7.66%)

07:35
08/22/19
08/22
07:35
08/22/19
07:35
Hot Stocks
Breaking Hot Stocks news story on Clearside Biomedical »

Clearside Biomedical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:34
08/22/19
08/22
07:34
08/22/19
07:34
Hot Stocks
Dick's Sporting says continuing strategic review of hunt business »

The company is continuing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:33
08/22/19
08/22
07:33
08/22/19
07:33
Hot Stocks
Dick's Sporting sees FY19 SSS growth in 'low single-digits' »

Consolidated same store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:31
08/22/19
08/22
07:31
08/22/19
07:31
Earnings
Dick's Sporting raises FY19 EPS view to $3.30-$3.45 from $3.20-$3.40 

FY19 consensus $3.31.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

PSTG

Pure Storage

$13.87

0.2 (1.46%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Oct

  • 12

    Dec

  • 16

    Dec

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Earnings
Dick's Sporting reports Q2 EPS $1.26, consensus $1.21 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.